MC
TECH icon

Menta Capital’s Bio-Techne TECH Stock Holding History

Menta Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-40,908
Closed -$1.51M – 706
2018
Q2 		$1.51M Buy
40,908
+8,832
+28% +$337K 0.35% 43
2018
Q1 		$1.21M Buy
+32,076
New +$1.13M 0.26% 126
2017
Q2 		– Sell
-13,812
Closed -$351K – 917
2017
Q1 		$351K Buy
+13,812
New +$357K 0.03% 652

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Menta Capital's TECH Position: Q3 2018 in Review

Menta Capital sold out of Bio-Techne (TECH) in Q3 2018, closing a stake of 40,908 shares — an estimated $1.51M sold.

Menta Capital first reported a position in TECH in Q1 2017 and held it in 3 quarters. The position peaked at $1.51M in Q2 2018. 344 funds tracked by Wall St. Rank hold TECH as of Q3 2018.

  • Menta Capital reported no remaining Bio-Techne position as of Q3 2018 after selling out during the quarter.
  • Menta Capital sold 40,908 Bio-Techne shares in Q3 2018, an estimated $1.51M.
  • Menta Capital first reported a position in Bio-Techne in Q1 2017 and held it in 3 quarters.
  • Menta Capital's Bio-Techne position peaked at $1.51M in Q2 2018.
  • 344 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2018.

Based on Menta Capital's 13F filing for Q3 2018, filed 14 Nov 2018.